Second primary neoplasms in patients with retinoblastoma.
about
Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigenMelanoma: from mutations to medicineRadiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.Early onset sebaceous carcinoma.Genetic predispositions and childhood cancer.Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS).Incidence and survival of malignant bone sarcomas in England 1979-2007.Secondary acute myeloid leukemia after successful treatment for osteosarcoma.Cancer screening practices of adult survivors of retinoblastoma at risk of second cancersApplication of PCR amplification of DNA from paraffin embedded tissue sections to linkage analysis in familial retinoblastoma.Genes and cancerUmbilical cord blood transplantation.Insights into cancer from transgenic mouse models.Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.Malignant melanoma in families of children with osteosarcoma, chondrosarcoma, and adrenal cortical carcinoma.Genes and environment: effects on the development of second malignancies in retinoblastoma survivors.Osteosarcoma Overview.Radiation-Induced Sarcoma Following Treatment of Breast Cancer.p53 functions as a cell cycle control protein in osteosarcomasRisk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapyDeletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein.Sarcomas in hereditary retinoblastomaNo excess of early onset cancer in family members of Wilms tumor patients.Lifetime risks of common cancers among retinoblastoma survivors.Patterns of risk of hereditary retinoblastoma and applications to genetic counselling.Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.Genomic Classification of Cutaneous MelanomaGenetic variation as a modifier of association between therapeutic exposure and subsequent malignant neoplasms in cancer survivors.p107 is a suppressor of retinoblastoma development in pRb-deficient mice.Deletion of RB exons 24 and 25 causes low-penetrance retinoblastomaSoft tissue, pelvic, and urinary bladder leiomyosarcoma as second neoplasm following hereditary retinoblastomaConcurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAFCDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.Neuronal and glial properties of a murine transgenic retinoblastoma model.Epidemiology and genetics of childhood cancer.Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer.Variation of second cancer risk by family history of retinoblastoma among long-term survivors.Trends in survival for childhood cancer in Britain diagnosed 1971-85An estimate of the heritable fraction of childhood cancerResponse of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.
P2860
Q24337366-FB1EA12A-D671-475B-8336-80493742C3EAQ27024061-F139B552-ABA2-445F-B63A-08B3C896F678Q30368547-ACD572A1-B953-4E65-B216-0BCCEB27BD1DQ30430631-2F471968-981A-4210-A0DB-42D65A2228B6Q30499276-85A15974-EFC9-4422-BC26-F5B4FB73FD0DQ30847332-33251AEC-8597-4F5D-BC6D-48B9181B24F1Q33274226-E8CC8F62-FF5F-4C27-96B6-81A80594B7EDQ33392211-89DA9BA0-1BA1-4791-8971-3FDA69A0E31BQ33575528-353D5A60-708B-4D2C-97B2-9BC0278647A9Q33596814-EA03016F-1D9D-4581-8790-E9EEEE8BB51FQ33634103-67691F5A-D33A-4C0C-A732-4FB49968B2EFQ33634109-DDCBEF49-5B6B-4874-A9B8-5DB4572C4A98Q33643327-084B1A20-334C-4673-BDEE-330E349582C3Q33646521-AAAEE253-1E70-40CF-AAEB-E4F9D94723D6Q33676204-E35B36E6-D757-448B-AC8A-DE32B48E8E1AQ33705736-021EB9BC-707C-4E3C-B58F-46193C3B4722Q33725511-A1F43DB3-DED6-4CDE-93DD-58E84D426DC8Q33889270-4E452E74-E5BA-4C75-AA37-F2AF4E8C2C4EQ34254691-BBA44A88-CD6F-4223-B17A-495656D5EBFBQ34260518-A7FD0346-3266-4FCC-8D7F-524631D8B577Q34378874-1878CF84-6C16-4C97-B21F-4B14E099F437Q34433701-858AB02A-DC17-4C19-80F6-AB63CADEA70DQ34464257-6A9315E2-E48B-4DED-B549-DD0261AA72C8Q34546040-3CAB81CC-A05A-4519-9E8E-4F04FAD6DD27Q34563696-FFCE668C-B347-4458-AB6C-6FBDD11591D7Q34621002-998D0E7E-A903-4024-AF1D-5C2D049665A1Q34670776-8D785BE3-9343-4B5E-A8C7-52F493DB3867Q35117677-EC51D4C7-CEE6-4BE7-BF41-2EEFF1462BD2Q35201543-F3460D14-052A-4754-A700-835C21C8A978Q35249353-D0F54FD6-CD16-4903-8338-392D0173D315Q35586666-B09790FD-B3C4-4F79-AF2A-DE52CBF7EA29Q35700459-9CD961D4-01F4-4CF5-80B8-B59CA8C79833Q35753196-973C750C-7672-4989-BA00-E350C11122AEQ35830265-9E9AF4DD-7C5A-43D5-8DC8-AD5323A8EA65Q35868038-DA8894F3-0AD6-4558-8181-1B373EA1ADEDQ35898678-72EF746C-038A-42F1-AADC-EEA459EDC268Q35925143-C0703F61-C770-4CEE-8271-AE1A2C782453Q35982185-AF6F9D9C-51CB-406B-B5F4-B5DF31801DCAQ35984730-72A95C2E-1023-4046-93E2-023492E5407BQ36028078-10B08912-DCB3-40F4-A183-D4C374D50F5A
P2860
Second primary neoplasms in patients with retinoblastoma.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Second primary neoplasms in patients with retinoblastoma.
@ast
Second primary neoplasms in patients with retinoblastoma.
@en
type
label
Second primary neoplasms in patients with retinoblastoma.
@ast
Second primary neoplasms in patients with retinoblastoma.
@en
prefLabel
Second primary neoplasms in patients with retinoblastoma.
@ast
Second primary neoplasms in patients with retinoblastoma.
@en
P2093
P2860
P356
P1476
Second primary neoplasms in patients with retinoblastoma.
@en
P2093
B M Sanders
G J Draper
J E Kingston
P2860
P2888
P304
P356
10.1038/BJC.1986.110
P407
P577
1986-05-01T00:00:00Z